Lumican as a novel potential clinical indicator for acute aortic dissection: A comparative study, based on multi-slice computed tomography angiography

  • Authors:
    • Guorong Gu
    • Fang Wan
    • Yuan Xue
    • Weizhong Cheng
    • Haiyin Zheng
    • Yun Zhao
    • Fan Fan
    • Yi Han
    • Chaoyang Tong
    • Chenling Yao
  • View Affiliations

  • Published online on: January 22, 2016     https://doi.org/10.3892/etm.2016.3020
  • Pages: 923-928
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The aim of the present study was to investigate the association between serum lumican levels and acute aortic dissection (AAD) severity. A total of 82 patients with chest or back pain and 30 healthy volunteers were recruited. Among the patients, there were 70 cases of AAD and 12 cases of intramural hematoma (IMH). AAD severity was determined using multi‑slice computed tomography angiography (MSCTA). Serum was collected from the patients upon admission, and lumican levels were detected using an enzyme‑linked immunosorbent assay. In addition, correlation analyses were conducted between lumican levels and AAD severity by designing a ‘SCORE X, RANGE Y’ system to measure the number of affected vital arteries and vertical range of false lumen, based on the MSCTA. Lumican levels differed significantly among the AAD patients (2.32±4.29 ng/ml), IMH patients (0.72±0.32 ng/ml) and healthy volunteers (0.85±0.53 ng/ml; P=0.003). In the AAD patients presenting within 12‑72 h of symptom onset, the Spearman's rho correlation coefficient between lumican and SCORE or RANGE was 0.373 (P=0.046) and 0.468 (P=0.010), respectively. The present results suggest that lumican may be a potential marker for aiding the diagnosis and screening for AAD, and may be used to predict the severity of AAD.
View Figures
View References

Related Articles

Journal Cover

March-2016
Volume 11 Issue 3

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Gu G, Wan F, Xue Y, Cheng W, Zheng H, Zhao Y, Fan F, Han Y, Tong C, Yao C, Yao C, et al: Lumican as a novel potential clinical indicator for acute aortic dissection: A comparative study, based on multi-slice computed tomography angiography. Exp Ther Med 11: 923-928, 2016
APA
Gu, G., Wan, F., Xue, Y., Cheng, W., Zheng, H., Zhao, Y. ... Yao, C. (2016). Lumican as a novel potential clinical indicator for acute aortic dissection: A comparative study, based on multi-slice computed tomography angiography. Experimental and Therapeutic Medicine, 11, 923-928. https://doi.org/10.3892/etm.2016.3020
MLA
Gu, G., Wan, F., Xue, Y., Cheng, W., Zheng, H., Zhao, Y., Fan, F., Han, Y., Tong, C., Yao, C."Lumican as a novel potential clinical indicator for acute aortic dissection: A comparative study, based on multi-slice computed tomography angiography". Experimental and Therapeutic Medicine 11.3 (2016): 923-928.
Chicago
Gu, G., Wan, F., Xue, Y., Cheng, W., Zheng, H., Zhao, Y., Fan, F., Han, Y., Tong, C., Yao, C."Lumican as a novel potential clinical indicator for acute aortic dissection: A comparative study, based on multi-slice computed tomography angiography". Experimental and Therapeutic Medicine 11, no. 3 (2016): 923-928. https://doi.org/10.3892/etm.2016.3020